Recent Quotes
My Watchlist
Indicators
Local Stocks
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Acer Therapeutics Inc (NQ: ACER )

1.500 -0.020 (-1.32%)
Streaming Delayed Price Updated: 1:18 PM EDT, Aug 11, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 33,907
Open 1.510
Bid (Size) 1.500 (2)
Ask (Size) 1.510 (6)
Prev. Close 1.520
Today's Range 1.500 - 1.550
52wk Range 1.163 - 3.770
Shares Outstanding 15,310,244
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Recap Of Thursday's Biotech Catalysts - End of The Day Summary
 
Via Benzinga
FDA Accepts Acer's Inborn Metabolism Disorder Therapy Refiling For Review
The U.S. Food and Drug Administration (FDA) has accepted for review Acer Therapeutics’ (NASDAQ: ACER) resubmission of New Drug Application (NDA) for ACER-001 (sodium phenylbutyrate) for oral suspension... 
Via Benzinga

Performance

YTD
-36.17%
-36.17%
1 Month
+3.45%
+3.45%
3 Month
-14.77%
-14.77%
6 Month
-35.90%
-35.90%
1 Year
-40.94%
-40.94%

More News

Read More
Daily Biotech Pulse: GSK's Kidney Disease Drug Approved For Children, Tonix Pharma To Launch Monkeypox Vaccine Study In Kenya, Positive Effect Of Cyclerion's Schizophrenia Candidate
Via Benzinga
Recap of Monday's Biotech Catalysts - End of the Day Summary
Via Benzinga
Acer Therapeutics: Q1 Earnings Insights
Via Benzinga
Tesla, Twitter And 76 Biggest Movers From Friday
Via Benzinga
Here's Why Acer Therapeutics Shares Are Moving
Via Benzinga
Tesla, WD-40 Company And 40 Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Attention Biotech Investors: Mark Your Calendar For These July PDUFA Dates
Via Benzinga
Recap of Tuesday's Biotech Catalysts - End of the Day Summary
Via Benzinga
67 Biggest Movers From Yesterday
Via Benzinga
FDA Rejects Acer Therapeutics - Relief Therapeutics' Urea Cycle Disorder Candidate
Via Benzinga
Acer Therapeutics' Stock Down As FDA Rejects Inborn Metabolism Disorder (UCD) Candidate
Via Benzinga
95 Biggest Movers From Yesterday
Via Benzinga
52 Stocks Moving In Monday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
The Week Ahead In Biotech (June 5-11): Adcom Test For Novavax, ASCO Presentations, Enzo Biochem Earnings And More
Via Benzinga
Attention Biotech Investors: Mark Your Calendar For These June PDUFA Dates
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
24 Stocks Moving in Tuesday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Acer Therapeutics and Relief Therapeutics Announce Presentation of ACER-001 Data at the Genetic Metabolic Dieticians International Conference
From Relief Therapeutics Holdings AG
Via AccessWire
Exposures Product Safety
Acer Therapeutics and Relief Therapeutics Announce Presentation of ACER-001 Data at the Society for Inherited Metabolic Disorders Annual Meeting
From Relief Therapeutics Holdings AG
Via AccessWire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.